Weibo Wang

This inventor holds 38 USPTO granted patents and 16 published patent applications, plus 5 CIPO patents and 20 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Shanghai Fochon Pharmaceutical Co., Ltd., Fochon Pharmaceuticals, Ltd.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weibo Wang. Retrieved from https://idiyas.com/inventor/weibo-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 16)

% Patents Active = 44.7

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 20 (Patent Applications = 28)

Average Co-Inventor Count = 8.1

ph-index = 6

Forward Citations = 147(Granted Patents)

Company Filing History:

13 out of 245

Novartis Vaccines & Diagnostics, Gmbh

patents

13 out of 13

Shanghai Fochon Pharmaceutical Co., Ltd.

patents

7 out of 7

Fochon Pharmaceuticals, Ltd.

patents

4. 3 out of 3,363

Chinese Academy of Sciences

patents

5. 3 out of 3

Chongqing Fochon Pharmaceutical Co., Ltd.

Fochon Biosciences, Ltd.

Fochon Pharmaceutical Co., Ltd.

patent

11. 1 out of 4

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Apoptosis-Inducing Agents

Protein Kinase Inhibitors

Quinazoline Derivatives

Indole Derivatives

Benzimidazole Derivatives

Cyclized Derivatives

Dipeptidyl Peptidase Inhibitors

Mitotic Kinesin Inhibitors

Thiosemicarbazones

Heteroaryl-Fused Compounds

Tetrahydrocarboline Compounds

Macrocyclic Compounds

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312349 - Apoptosis-inducing agents (2025-05-27),

2. 11555042 - Macrocyclic compounds as TRK kinases inhibitors (2023-01-17),

3. 11485707 - Deuterated compounds as rock inhibitors (2022-11-01),

4. 11459332 - Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors (2022-10-04),

5. 11168078 - Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase (2021-11-09),

6. 11091478 - Apoptosis-inducing agents (2021-08-17),

7. 11053239 - Compounds as BLC-2-selective apoptosis-inducing agents (2021-07-06),

8. 10894038 - Indolizine derivatives, composition and methods of use (2021-01-19),

9. 10835535 - Certain protein kinase inhibitors (2020-11-17),

10. 10800785 - Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors (2020-10-13),

11. 10450316 - Certain protein kinase inhibitor (2019-10-22),

12. 10328060 - Certain protein kinase inhibitors (2019-06-25),

13. 10087195 - Certain protein kinase inhibitors (2018-10-02),

14. 10053449 - Quinazoline derivatives, compositions thereof, and use as pharmaceuticals (2018-08-21),

15. 10022374 - Certain protein kinase inhibitors (2018-07-17),

Title: The Innovative Journey of Inventor Weibo Wang

Introduction: Weibo Wang, a talented inventor hailing from Moraga, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Wang's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles and smart home systems.

Career Highlights: With a background in computer science and engineering, Wang has a successful track record of developing innovative solutions for complex technological challenges. He has received numerous accolades for his work in the field.

Collaborations: Wang has collaborated with leading tech companies and research institutions to further push the boundaries of innovation. His partnerships have resulted in the development of revolutionary products that have changed the way we interact with technology.

Conclusion: Weibo Wang's passion for innovation and his dedication to pushing the limits of technology make him a true pioneer in the field of inventions. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.